Readystate Asset Management LP Protagonist Therapeutics, Inc Transaction History

Readystate Asset Management LP

  • $3.08 Trillion
  • Q2 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 14, 2024
SELL
$14.05 - $23.44 $1.79 Million - $2.98 Million
-127,141 Reduced 68.97%
57,206 $1.31 Billion
Q3 2023

Nov 14, 2023
SELL
$16.68 - $23.66 $342,490 - $485,810
-20,533 Reduced 10.02%
184,347 $3.07 Billion
Q2 2023

Aug 14, 2023
BUY
$18.02 - $29.36 $3.69 Million - $6.02 Million
204,880 New
204,880 $5.66 Billion

Others Institutions Holding PTGX

# of Institutions
212
Shares Held
59.1M
Call Options Held
19K
Put Options Held
107K
View Full List

About Protagonist Therapeutics, Inc

PTGX Quotes by TradingView
  • Ticker PTGX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 49,084,100
  • Market Cap $2.25B
  • Description
  • Protagonist Therapeutics, Inc., a biopharmaceutical company, discovers and develops peptide-based therapeutic drugs to address hematology and blood disorders, and inflammatory and immunomodulatory diseases. It is developing rusfertide (PTG-300), an injectable hepcidin mimetic that is in Phase II clinical trials for the treatment of patients with...
More about PTGX
Track This Portfolio

Track Readystate Asset Management LP Portfolio

Follow Readystate Asset Management LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Readystate Asset Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Readystate Asset Management LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email